These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 9858427

  • 1. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B.
    J Rheumatol; 1998 Dec; 25(12):2339-44. PubMed ID: 9858427
    [Abstract] [Full Text] [Related]

  • 2. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Racadot A, Boersma A, Delcambre B.
    Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
    [Abstract] [Full Text] [Related]

  • 3. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [Abstract] [Full Text] [Related]

  • 4. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 5. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U, Teichmann J, Müller-Ladner U, Strunk J.
    Rheumatology (Oxford); 2005 Dec 15; 44(12):1546-8. PubMed ID: 16263785
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.
    Cortet B, Flipo RM, Blanckaert F, Duquesnoy B, Marchandise X, Delcambre B.
    Rev Rhum Engl Ed; 1997 Dec 15; 64(7-9):451-8. PubMed ID: 9338926
    [Abstract] [Full Text] [Related]

  • 7. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
    Burshell AL, Möricke R, Correa-Rotter R, Chen P, Warner MR, Dalsky GP, Taylor KA, Krege JH.
    Bone; 2010 Apr 15; 46(4):935-9. PubMed ID: 20060081
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
    Ann Rheum Dis; 2008 Mar 15; 67(3):353-7. PubMed ID: 17644538
    [Abstract] [Full Text] [Related]

  • 9. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
    Delmas PD, Licata AA, Reginster JY, Crans GG, Chen P, Misurski DA, Wagman RB, Mitlak BH.
    Bone; 2006 Aug 15; 39(2):237-43. PubMed ID: 16563890
    [Abstract] [Full Text] [Related]

  • 10. The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.
    Pullerits R, d'Elia HF, Tarkowski A, Carlsten H.
    Rheumatology (Oxford); 2009 Jul 15; 48(7):785-90. PubMed ID: 19416946
    [Abstract] [Full Text] [Related]

  • 11. Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.
    Kruger MC, Booth CL, Coad J, Schollum LM, Kuhn-Sherlock B, Shearer MJ.
    Nutrition; 2006 Jul 15; 22(11-12):1120-8. PubMed ID: 17030114
    [Abstract] [Full Text] [Related]

  • 12. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.
    J Bone Miner Res; 1994 May 15; 9(5):631-7. PubMed ID: 8053391
    [Abstract] [Full Text] [Related]

  • 13. Relationship between bone turnover and bone density at the proximal femur in stroke patients.
    Paker N, Bugdayci D, Tekdos D, Dere C, Kaya B.
    J Stroke Cerebrovasc Dis; 2009 May 15; 18(2):139-43. PubMed ID: 19251190
    [Abstract] [Full Text] [Related]

  • 14. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
    Lormeau C, Soudan B, d'Herbomez M, Pigny P, Duquesnoy B, Cortet B.
    Bone; 2004 Jun 15; 34(6):933-9. PubMed ID: 15193539
    [Abstract] [Full Text] [Related]

  • 15. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN, Kandemir N.
    Clin Endocrinol (Oxf); 2007 May 15; 66(5):672-7. PubMed ID: 17381489
    [Abstract] [Full Text] [Related]

  • 16. Cross-sectional evaluation of bone metabolism in men.
    Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD.
    J Bone Miner Res; 2001 Sep 15; 16(9):1642-50. PubMed ID: 11547833
    [Abstract] [Full Text] [Related]

  • 17. Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women.
    Akesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gärdsell P, Obrant KJ.
    J Bone Miner Res; 1995 Nov 15; 10(11):1823-9. PubMed ID: 8592961
    [Abstract] [Full Text] [Related]

  • 18. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer.
    Arikoski P, Komulainen J, Riikonen P, Parviainen M, Jurvelin JS, Voutilainen R, Kröger H.
    J Bone Miner Res; 1999 Dec 15; 14(12):2002-9. PubMed ID: 10620058
    [Abstract] [Full Text] [Related]

  • 19. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P, Munoz F, Marchand F, Chapuy MC, Delmas PD.
    Calcif Tissue Int; 2003 Dec 15; 73(6):520-30. PubMed ID: 12958693
    [Abstract] [Full Text] [Related]

  • 20. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
    Szentpetery A, McKenna MJ, Murray BF, Ng CT, Brady JJ, Morrin M, Radovits B, Veale DJ, Fitzgerald O.
    J Rheumatol; 2013 May 15; 40(5):653-62. PubMed ID: 23457381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.